AniPharm ApS: Financial statements 2020
CVR: 40014535
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AniPharm ApS (CVR 40014535) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,750 and a net result of DKK -5,488. Equity in the 2020 report amounted to DKK 40,566. The solvency ratio was 82.3%.
- Gross Profit
- DKK -3,750
- Profit/Loss
- DKK -5,488
- Equity
- DKK 40,566
- Total Assets
- DKK 49,316
- Employees
- 0
Official annual report
How creditworthy is AniPharm ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AniPharm ApS has published its interim report for the period November 9, 2018 – December 31, 2019.
About AniPharm ApS
AniPharm ApS was a Danish company of the type Anpartsselskab based in Odder, founded in 2018. The company has been dissolved on 5 October 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -3,750 and a net result of DKK -5,488. Equity in the 2020 report amounted to DKK 40,566.